RGO:ETR
Regeneron Pharmaceuticals Inc
€633,80
arrow_downward
-0,39%(-2,50) 1G
17 Nis, 17:35:30 GMT+2 · EUR
search
Tüm semboller
1G
5G
1A
6A
Yıl Başından Beri
1Y
5Y
MAKS
| Sembol | Fiyat | Değişiklik | Değişiklik % |
|---|
Haberler
Web genelindeki kaynaklardan
MarketBeat
·
4 saat önce
Insider Selling: Regeneron Pharmaceuticals (NASDAQ:REGN) Director Sells 100 Shares of Stock
MarketBeat
·
1 gün önce
PKO Investment Management Joint Stock Co Has $3.74 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN
The Motley Fool
·
2 gün önce
Is Regeneron a Buy After the FDA Approved its Gene Therapy to Restore Hearing?
Simply Wall Street
·
2 gün önce
A Look At Regeneron Pharmaceuticals (REGN) Valuation After Recent Share Price Weakness
Profil
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
Yapay zeka içeriklerinde hata olabilir. Daha fazla bilgi